NFX
Last updated:
Investment Thesis
NFX identifies and backs founders building companies with network effects. The fund emphasizes software development, founder support through content/tools, and emerging technologies including AI, biotech, and infrastructure.
Investment Profile
- Stage: Seed, Series_a
- Sectors: AI/ML, Biotech, Healthcare, Legal Tech, SaaS, Space/Infrastructure, Logistics
- Check size: $250K–$2M
- Geography: US
Investment Team
- Anna Piñol — Partner
- Daniel Museles — Principal
- Gigi Levy-Weiss — General Partner
- James Currier — Managing Partner
- Omri Drory — Ph.D.
- Pete Flint — General Partner
Frequently Asked Questions
What does NFX invest in?
NFX is a seed, series_a stage AI/ML, Biotech, Healthcare, Legal Tech, SaaS, Space/Infrastructure, Logistics investor, typically writing $250K–$2M checks, primarily investing in US. Their thesis: NFX identifies and backs founders building companies with network effects. The fund emphasizes software development, founder support through content/tools, and emerging technologies including AI, biotech, and infrastructure.
How do I get a meeting with NFX?
Use DryPowder's AI fund matching to see exactly how your startup aligns with NFX's thesis and portfolio. The tool gives you a fit score and specific talking points tailored to NFX's focus areas (AI/ML, Biotech, Healthcare, Legal Tech, SaaS, Space/Infrastructure, Logistics), so you can approach them with confidence.
Is NFX actively deploying capital?
DryPowder tracks deployment signals for NFX — including recent deals, LP closes, and portfolio news. Signal subscribers get real-time alerts when NFX makes moves, so you can reach out when the timing is right.
Is NFX right for your startup?
Use DryPowder's AI fund matching to see how NFX compares to your raise profile — and find the best-fit investors from 500+ tracked funds.